Instructions & Forms
The facility is dedicated for work involving pathogenic Risk Group II and III viral agents, including HIV-1, HIV-2, HTLV-I, Hepatitis B and other indigenous human pathogens. Experiments involving the production and analysis of recombinant viral vectors expressing potentially hazardous gene products may also be performed in the facility. Projects require prior approval by the University Core review committee and the recombinant DNA advisory committees before any procedures can be performed in the facility.
To obtain approval to use the facility, please contact Steven King to initiate the application and review process.